Abstract

Background: Septic shock, a major cause of death in critical care, is the clinical translation of a cytokine storm in response to infection. It can be complicated by sepsis-induced immunosuppression, exemplified by blood lymphopenia, an excess of circulating Treg lymphocytes, and decreased HLA-DR expression on circulating monocytes. Such immunosuppression is associated with secondary infections, and higher mortality. The effect of these biological modifications on circulating innate lymphoid cells (ILCs) has been little studied.Methods: We prospectively enrolled patients with septic shock (Sepsis-3 definition) in the intensive care unit (ICU) of Timone CHU Hospital. ICU controls (trauma, cardiac arrest, neurological dysfunction) were recruited at the same time (NCT03297203). We performed immunophenotyping of adaptive lymphocytes (CD3+ T cells, CD19+ B cells, CD4+CD25+FoxP3+ Treg lymphocytes), ILCs (CD3−CD56+ NK cells and helper ILCs – ILC1, ILC2, and ILC3), and monocytes by flow cytometry on fresh blood samples collected between 24 and 72 h after admission.Results: We investigated adaptive and innate circulating lymphoid cells in the peripheral blood of 18 patients in septic shock, 15 ICU controls, and 30 healthy subjects. As expected, the peripheral blood lymphocytes of all ICU patients showed lymphopenia, which was not specific to sepsis, whereas those of the healthy volunteers did not. Circulating CD3+ T cells and CD3−CD56+ NK cells were mainly concerned. There was a tendency toward fewer Treg lymphocytes and lower HLA-DR expression on monocytes in ICU patients with sepsis. Although the ILC1 count was higher in septic patients than healthy subjects, ILC2, and ILC3 counts were lower in both ICU groups. However, ILC3s within the total ILCs were overrepresented in patients with septic shock. The depression of immune responses has been correlated with the occurrence of secondary infections. We did not find any differences in ILC distribution according to this criterion.Conclusion: All ICU patients exhibit lymphopenia, regardless of the nature (septic or sterile) of the initial medical condition. Specific distribution of circulating ILCs, with an excess of ILC1, and a lack of ILC3, may characterize septic shock during the first 3 days of the disease.

Highlights

  • Sepsis and septic shock are major public health concerns

  • We compared critically ill patients who had a secondary infection during their stay in the Intensive Care Unit (ICU) vs. patients who did not to assess the role of “biomarkers depression” in the occurrence of secondary infections

  • The median SOFA score was higher for the Sepsis Group (8 [4,5,6,7,8,9,10,11,12,13,14,15]) than the ICU controls (6 [2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17]; p = 0.10)

Read more

Summary

Introduction

Sepsis and septic shock are major public health concerns. In the absence of therapeutic advances, septic shock is a leading cause of mortality in critically ill patients (1). The phagocytosis of peripheral blood neutrophils can be altered, leading to VAP (4), as reduced IFN-γ production by natural killer (NK) cells is associated with CMV reactivation (5) Activation markers, such as HLA-DR (MHC class II), on circulating monocytes are underexpressed in septic patients (6), especially in the later stages of the disease (> 72 h) (7), and this is associated with secondary infections, and mortality. A major cause of death in critical care, is the clinical translation of a cytokine storm in response to infection It can be complicated by sepsis-induced immunosuppression, exemplified by blood lymphopenia, an excess of circulating Treg lymphocytes, and decreased HLA-DR expression on circulating monocytes. Such immunosuppression is associated with secondary infections, and higher mortality. The effect of these biological modifications on circulating innate lymphoid cells (ILCs) has been little studied

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call